StockData
Medtronic plc logo

Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic specialty Therapies (Neurovascular, ENT & Pelvic Health) — Organic Revenue Growth YoY (%) (%)

Medtronic Form 8-K World-Wide Revenue Tables (Published Organic Growth)

Latest, FY2026
0.3%
Period ended Apr 30, 2026
Change on a year earlier
-1.5 pts
1.8% in FY2025
History
8 years
Since FY2018
Sources
8
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSpecialty Therapies (Neurovascular, ENT & Pelvic Health) — Organic Revenue Growth YoY (%) (%)Year on yearSource
FY2026Apr 30, 20260.3%-1.5 ptsMedtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗
FY2025Apr 30, 20251.8%-1.8 ptsMedtronic SEC 8K_EARNINGS — FY2025Q4 (filed 2025-05-21) ↗
FY2024Apr 30, 20243.6%-5.4 ptsMedtronic SEC 8K_EARNINGS — FY2024Q4 (filed 2024-05-23) ↗
FY2023Apr 30, 20239.0%-2.8 ptsMedtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗
FY2022Apr 30, 202211.8%+5.6 ptsMedtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗
FY2021Apr 30, 20216.2%+14.1 ptsMedtronic SEC 8K_EARNINGS — FY2021Q4 (filed 2021-05-27) ↗
FY2020Apr 30, 2020-7.9%–Medtronic SEC 8K_EARNINGS — FY2020Q4 (filed 2020-05-21) ↗
FY2018Apr 30, 20183.0%–Medtronic SEC 8K_EARNINGS — FY2018Q4 (filed 2018-05-24) ↗

Cite this data

StockData. (2026). Medtronic Specialty Therapies (Neurovascular, ENT & Pelvic Health) — Organic Revenue Growth YoY (%) (%), annual FY2018–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/neuro-st-ww-org

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.